Gathering information on pediatric patients with Antiphospholipid Syndrome
Register for Pediatric Patients With Antiphospholipid Syndrome (APS): European Project Extended Internationally Study
University of California, Davis · NCT00616317
This study is gathering information on children with Antiphospholipid Syndrome to better understand its causes and treatments.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 50 (estimated) |
| Ages | 1 Minute to 18 Years |
| Sex | All |
| Sponsor | University of California, Davis (other) |
| Locations | 1 site (Sacramento, California) |
| Trial ID | NCT00616317 on ClinicalTrials.gov |
What this trial studies
This observational study aims to collect data on the causes and treatment of Antiphospholipid Syndrome (APS) in pediatric patients. It focuses on individuals who were 18 years old or younger at the onset of the disease and have experienced vascular thrombosis. The study will involve patients from UC Davis Medical Center and will utilize laboratory criteria to confirm the diagnosis of APS. By compiling this information, the study seeks to enhance understanding and management of APS in children.
Who should consider this trial
Good fit: Ideal candidates for this study are pediatric patients diagnosed with Antiphospholipid Syndrome who experienced symptoms before the age of 18.
Not a fit: Patients who are infants born to mothers with APS or those with congenital thrombophilia may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve the diagnosis and treatment strategies for pediatric patients with Antiphospholipid Syndrome.
How similar studies have performed: While this study is observational and focuses on gathering data, similar studies have previously contributed valuable insights into the management of Antiphospholipid Syndrome.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18 years of age or younger at the onset of disease * Presence of Vascular Thrombosis * UC Davis patient * Presence of at least one Laboratory criteria including: Anticardiolipin antibody, Anti-B glycoprotein-I antibody or Lupus anticoagulant in plasma Exclusion Criteria: * Infants born to mothers with APS * Infants with congenital thrombophilia
Where this trial is running
Sacramento, California
- UC Davis Medical Center — Sacramento, California, United States (RECRUITING)
Study contacts
- Principal investigator: Lavjay Butani, M.D. — University of California, Davis
- Study coordinator: Lavjay Butani
- Phone: (916) 734-8118
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Antiphospholipid Syndrome